Zoetis Inc.
ZTS
Zoetis Inc. is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. We have a diversified business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattl…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$9.49B
▲ +2.3% YoY
Net Income (TTM)
$2.51B
▲ +7.5% YoY
Op. Margin
39.00%
▲ +1.2pp YoY
ROIC
24.53%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$2.23B
▼ -0.7% YoY
Op. Cash Flow (TTM)
$2.73B
▼ -1.7% YoY
Net Debt
$7.70B
Cash & Equiv.
$1.53B
5Y CAGR: +7.2%
5Y CAGR: +6.4%
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with ZTS
Held by ETFs
ZTS is in 308 US ETFs. The largest of them, with ZTS's weight in each:
Zoetis (ZTS) in four numbers
Questions about Zoetis
Is Zoetis (ZTS) overvalued?
At $79.83, Zoetis' price is 48% below the $152.67 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 13.46 times earnings and 14.51 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Zoetis' fair value?
Intrinsiqq's calculator puts Zoetis' fair value at $152.67 a share. It grows earnings per share 12% a year for 5 years, applies an exit P/E of 21.8, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $114.50. Every input can be changed on the Intrinsic Value tab.
Is Zoetis a high-quality business?
Zoetis scores 76 out of 100 on Intrinsiqq's quality score, which makes it a solid business on these measures. The score blends 8 checks computed from SEC filings. Its best check is cash flow growth at 13.9%, and its weakest is net debt at $7.70B. The Quality tab shows every check against its target.
Does Zoetis (ZTS) pay a dividend, and how much?
Yes. Zoetis (ZTS) pays a dividend: $2.12 per share over the last twelve months, a dividend yield of 2.73% at the latest close. It has raised its dividend per share for 13 years in a row, growing at 19.0% a year over the last 5 years. The payout takes about 35.3% of earnings.
Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: live 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ZTS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ZTS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.